We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+11.49%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$601M
AUM Growth
+$89M
(+17%)
Cap. Flow
+$40.9M
Cap. Flow
% of AUM
6.81%
Top 10 Holdings %
Top 10 Hldgs %
41.06%
Holding
94
New
4
Increased
28
Reduced
31
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$20.4M |
| 2 |
Eli Lilly
LLY
|
+$18.2M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$13.4M |
| 4 |
Monster Beverage
MNST
|
+$10.6M |
| 5 |
Dynatrace
DT
|
+$10.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$16.9M |
| 2 |
United Rentals
URI
|
+$10.7M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$8.54M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$8.32M |
| 5 |
Tesla
TSLA
|
+$7.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.55% |
| 3 | Consumer Discretionary | 10.9% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Union Pacific
UNP
$182B
| $525K | 0.09% |
2,564
| – | – |
|
77
Ecolab
ECL
$75.6B
| $401K | 0.07% |
2,150
| – | – |
|
78
Oracle
ORCL
$331B
| $397K | 0.07% |
3,333
+100
| +3% | +$10.3K |
|
79
NextEra Energy
NEE
$187B
| $356K | 0.06% |
4,800
| – | – |
|
80
Qorvo
QRVO
$7.63B
| $284K | 0.05% |
2,783
| – | – |
|
|
FISV
81
Fiserv Inc
FISV
$27.2B
| $260K | 0.04% |
2,063
| – | – |
|
82
Zoetis
ZTS
$31.6B
| $258K | 0.04% |
1,500
| – | – |
|
83
Amgen
AMGN
$203B
| $254K | 0.04% |
1,145
| – | – |
|
84
PepsiCo
PEP
$186B
| $240K | 0.04% |
1,296
+50
| +4% | +$9.33K |
|
85
Cummins
CMI
$91.7B
| $229K | 0.04% |
+933
| New | +$211K |
|
86
Royal Gold
RGLD
$17.1B
| $207K | 0.03% |
1,800
| – | – |
|
87
Clorox
CLX
$11.6B
| – | – |
-1,416
| Closed | -$224K |
|
|
88
iShares MSCI Emerging Markets ETF
EEM
$28B
| – | – |
-216,300
| Closed | -$8.54M |
|
89
LPL Financial
LPLA
$26.3B
| – | – |
-6,600
| Closed | -$1.34M |
|
90
Pfizer
PFE
$140B
| – | – |
-12,320
| Closed | -$503K |
|
|
91
Regeneron Pharmaceuticals
REGN
$68.8B
| – | – |
-20,590
| Closed | -$16.9M |
|
|
92
United Rentals
URI
$71.1B
| – | – |
-27,000
| Closed | -$10.7M |
|
93
Verizon
VZ
$194B
| – | – |
-22,446
| Closed | -$873K |
|
|
SPLK
94
DELISTED
Splunk Inc
SPLK
| – | – |
-86,800
| Closed | -$8.32M |
|
Similar funds
ECA
DWML
BOA
PLU
CPW
CAAM
SCP
EFMC
De Burlo Group's Q2 2023 Portfolio in Review
As of Q2 2023, De Burlo Group held 94 positions worth $601M, up 17% from $512M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
De Burlo Group deployed $40.9M of net new capital in Q2 2023, opening 4 new positions and adding to 28 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 114,300 shares worth $21.4M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $7.6M trimmed.
- De Burlo Group's largest Q2 2023 buy was iShares Russell 2000 ETF: 114,300 shares worth $21.4M.
- De Burlo Group added most to Eli Lilly in Q2 2023, an estimated $18.2M increase.
- De Burlo Group's biggest Q2 2023 reduction was Tesla, cutting an estimated $7.6M.
- De Burlo Group fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $16.9M.
- De Burlo Group's ten largest holdings make up 41% of its $601M portfolio in Q2 2023.
- De Burlo Group opened 4 new positions and closed 8 in Q2 2023.
- De Burlo Group's portfolio value rose 17% quarter-over-quarter to $601M.
Based on De Burlo Group's 13F filing for Q2 2023, filed 14 Aug 2023.